Arun Pandiri
Staff Scientist
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (6)
Year:
2025
Year:
2025
Lung cancer, the leading cause of cancer mortality, exhibits diverse histologic subtypes and genetic complexities. Numerous preclinical mouse models have been developed to study lung cancer, but data from these models are disparate, siloed, and difficult to compare in a centralized fashion. In this study, we established the Lung Cancer Autochthonous Model Gene Expression Database (LCAMGDB), an extensive repository of 1,354 samples from 77 transcriptomic datasets covering 974 samples from genetically engineered mouse models (GEMM), 368 samples from carcinogen-induced models, and 12 samples from a spontaneous model. Meticulous curation and collaboration with data depositors produced a robust and comprehensive database, enhancing the fidelity of the genetic landscape it depicts. The LCAMGDB aligned 859 tumors from GEMMs with human lung cancer mutations, enabling comparative analysis and revealing a pressing need to broaden the diversity of genetic aberrations modeled in the GEMMs. To accompany this resource, a web application was developed that offers researchers intuitive tools for in-depth gene expression analysis. With standardized reprocessing of gene expression data, the LCAMGDB serves as a powerful platform for cross-study comparison and lays the groundwork for future research, aiming to bridge the gap between mouse models and human lung cancer for improved translational relevance. Significance: The Lung Cancer Autochthonous Model Gene Expression Database (LCAMGDB) provides a comprehensive and accessible resource for the research community to investigate lung cancer biology in mouse models.
Year:
2025
The cancer hazard associated with lifetime exposure to radiofrequency radiation (RFR) was examined in Sprague Dawley (SD) rats at the Ramazzini Institute (RI), Italy. There were increased incidences of gliomas and cardiac schwannomas. The translational relevance of these rare rat tumors for human disease is poorly understood. We examined the genetic alterations in RFR-derived rat tumors through molecular characterization of important cancer genes relevant for human gliomagenesis. A targeted next-generation sequencing (NGS) panel was designed for rats based on the top 23 orthologous human glioma-related genes. Single-nucleotide variants (SNVs) and small insertion and deletions (indels) were characterized in the rat gliomas and cardiac schwannomas. Translational relevance of these genetic alterations in rat tumors to human disease was determined through comparison with the Catalogue of Somatic Mutations in Cancer (COSMIC) database. These data suggest that rat gliomas resulting from life-time exposure to RFR histologically resemble low grade human gliomas but surprisingly no mutations were detected in rat gliomas that had homology to the human IDH1 p.R132 or IDH2 p.R172 suggesting that rat gliomas are primarily wild-type for IDH hotspot mutations implicated in human gliomas. The rat gliomas appear to share some genetic alterations with IDH1 wildtype human gliomas and rat cardiac schwannomas also harbor mutations in some of the queried cancer genes. These data demonstrate that targeted NGS panels based on tumor specific orthologous human cancer driver genes are an important tool to examine the translational relevance of rodent tumors resulting from chronic/life-time rodent bioassays.
Year:
2024
Year:
2023
Year:
2023
Collaborators (24)
Kekoa Taparra
Assistant Professor
University of California, Los Angeles
John Minna
Professor and Direcdtor
University of Texas Southwestern Medical Center
Vassilis Aidinis
Biomedical Sciences Research Center Alexander Fleming
Barbara Grüner
University Hospital Essen
Phuoc T. Tran
University of Maryland
Pawel Mazur
Associate Professor
The University of Texas MD Anderson Cancer Center
Roger A. Moorehead
University of Guelph
Ralph J. DeBerardinis
University of Texas Southwestern Medical Center
Charles Rudin
Memorial Sloan Kettering Cancer Center
J. Edward van Veen
Assistant Adjunct Professor
University of California, Los Angeles
Takeshi Izawa
Associate Professor/Research Professor
Osaka University
George Acquaah-Mensah
Professor of Pharmaceutical Sciences
Massachusetts College of Pharmacy and Health Sciences
Yonathan Lissanu
The University of Texas MD Anderson Cancer Center
Trudy G. Oliver
Duke University
YING GAO
University of Texas Southwestern Medical Center
David MacPherson
Professor
Fred Hutch Cancer Center
Giorgio Ramadori
Scientific Collaborator
University of Geneva
Rosanna Martinelli
Professor of Molecular Biology
Università degli Studi di Napoli Federico II
Min Gyu Lee
Professor
The University of Texas MD Anderson Cancer Center
Shyam Biswal
Professor
Johns Hopkins University
CHARLES POWELL
Division Chief/Professor of Medicine
Icahn School of Medicine at Mount Sinai
Jennifer Beane-Ebel
Assistant Professor
Boston University School of Medicine
Guanghua Xiao
-
Yang Xie
Professor
University of Texas Southwestern Medical Center
Make your next move.
Prepare your application
Review drafts before you send them.